J.W. Burns & Co’s Boston Scientific BSX Stock Holding History

J.W. Burns & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,610	Closed	-$249K	–	184
2025 Q4	$249K	Buy	+2,610	New	+$256K	0.03%	167
2025 Q3	–	Sell	-2,000	Closed	-$215K	–	187
2025 Q2	$215K	Hold	2,000	–	–	0.03%	180
2025 Q1	$202K	Buy	+2,000	New	+$201K	0.03%	182

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

J.W. Burns & Co's BSX Position: Q1 2026 in Review

J.W. Burns & Co sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,610 shares — an estimated $249K sold.

J.W. Burns & Co first reported a position in BSX in Q1 2025 and held it in 3 quarters. The position peaked at $249K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

J.W. Burns & Co reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
J.W. Burns & Co sold 2,610 Boston Scientific shares in Q1 2026, an estimated $249K.
J.W. Burns & Co first reported a position in Boston Scientific in Q1 2025 and held it in 3 quarters.
J.W. Burns & Co's Boston Scientific position peaked at $249K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on J.W. Burns & Co's 13F filing for Q1 2026, filed 17 Apr 2026.